H91.0
Ototoxic hearing loss
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Code First
- poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)
Medical Intelligence & Overview
Ototoxic hearing loss refers to hearing impairment resulting from exposure to certain drugs or chemicals that damage the ear's inner structures, particularly the cochlea or auditory nerve. This condition can affect people of all ages who are undergoing treatments with ototoxic medications or are exposed to harmful substances. Recognizing this type of hearing loss is essential for early intervention and managing potential hearing deterioration.
Causes & Symptoms
Clinical Causes: Use of ototoxic medications such as aminoglycoside antibiotics (e.g., gentamicin, amikacin) Chemotherapy drugs like cisplatin and carboplatin High doses of loop diuretics such as furosemide and bumetanide Exposure to industrial chemicals like solvents and heavy metals Prolonged use of certain medications that may harm inner ear structures
Key Symptoms: Gradual or sudden hearing loss in one or both ears Tinnitus, or ringing in the ears A sense of fullness or pressure in the ear Dizziness or balance problems in some cases Difficulty understanding speech, especially in noisy environments
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of hearing tests, such as audiometry, to assess the extent of hearing loss. Medical history review is important to identify potential exposure to ototoxic agents. In some cases, otoacoustic emissions or brainstem evoked response audiometry (BERA) may be conducted for detailed evaluation. An examination of the ear structures by an audiologist or ENT specialist helps confirm the cause and extent of damage.
Treatment Protocols: Discontinuing or substituting ototoxic medications whenever possible Using hearing aids to amplify sounds and enhance hearing ability Implementing assistive listening devices for communication Providing auditory training and rehabilitation programs Monitoring hearing regularly during treatment courses involving ototoxic drugs Addressing balance issues or dizziness through targeted therapies
Clinical Advice & FAQs
Billing Guidance
Is H91.0 a billable ICD-10 code?
Yes, H91.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H91.0?
Clinical documentation must specify the nature of Ototoxic hearing loss and any associated comorbidities for accurate reporting.
Cite this Clinical Reference